Provided by Tiger Trade Technology Pte. Ltd.

Achieve Life Sciences, Inc.

4.61
-0.0700-1.50%
Post-market: 4.59-0.0180-0.39%19:05 EST
Volume:351.67K
Turnover:1.64M
Market Cap:245.41M
PE:-3.41
High:4.72
Open:4.68
Low:4.60
Close:4.68
52wk High:5.78
52wk Low:1.84
Shares:53.23M
Float Shares:44.42M
Volume Ratio:0.48
T/O Rate:0.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3500
EPS(LYR):-1.2418
ROE:-161.08%
ROA:-65.45%
PB:7.30
PE(LYR):-3.71

Loading ...

Achieve Life Sciences Grants Stock Options to New Executives and Employees

Reuters
·
Dec 09

Achieve Appoints Layla Revis as Senior Vice President of Marketing

THOMSON REUTERS
·
Dec 08

Achieve Life Sciences Initiated at Market Outperform by Citizens

Dow Jones
·
Nov 25

Lake Street Keeps Their Buy Rating on Achieve Life Sciences (ACHV)

TIPRANKS
·
Nov 08

Achieve Life Sciences Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 06

Achieve Life Sciences Q3 net loss widens

Reuters
·
Nov 06

Achieve Life Sciences Q3 Operating Expenses USD 14.692 Million

THOMSON REUTERS
·
Nov 06

Achieve Life Sciences Inc - Pdufa Date for Cytisinicline Set for June 20, 2026

THOMSON REUTERS
·
Nov 06

Achieve Life Sciences Q3 Net Income USD -14.441 Million VS. Ibes Estimate USD -12.2 Million

THOMSON REUTERS
·
Nov 06

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 06

Achieve Life Sciences Unveils Cytisinicline Strategy Targeting Nicotine Dependence Market

Reuters
·
Nov 05

Achieve Life Sciences Inc expected to post a loss of 26 cents a share - Earnings Preview

Reuters
·
Nov 04

Achieve Life Sciences announces several milestones in its ORCA-OL trial

TIPRANKS
·
Nov 03

Achieve Life Sciences Inc - Dsmc Finds No Serious Adverse Events in Orca-Ol Trial

THOMSON REUTERS
·
Nov 03

Achieve Life Sciences Inc: Dsmc Found No Concerns With Respect to Drug Safety

THOMSON REUTERS
·
Nov 03

Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline Nda for Smoking Cessation

THOMSON REUTERS
·
Nov 03

Achieve Life Sciences Inc. Files Initial Statement of Beneficial Ownership for Chief Legal Officer Erik Atkisson

Reuters
·
Oct 22

4 Biotech Stocks Lifting Off As Momentum Builds

Benzinga_recent_news
·
Oct 21

Press Release: Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer

Dow Jones
·
Oct 20

Achieve Life Sciences (ACHV) Is Up 36.4% After FDA Awards Rare Priority Voucher for Vaping Cessation Drug – Has the Bull Case Changed?

Simply Wall St.
·
Oct 20